Literature DB >> 1313855

Receptor-linked hydrolysis of phosphoinositides and production of prostacyclin in cerebral endothelial cells.

J Xu1, Z X Qu, S A Moore, C Y Hsu, E L Hogan.   

Abstract

The receptor agonist-mediated hydrolysis of phosphoinositides and production of prostacyclin were studied in murine cerebral endothelial cells (MCEC). Of 11 neurotransmitters and neuromodulators examined, carbachol, noradrenaline (NE), bradykinin, and thrombin significantly increased 3H-inositol phosphate accumulation in the presence of LiCl (20 mM). The maximal stimulation of [3H]inositol monophosphate ([3H]IP1) reached approximately 11, 11, seven, and four times the basal levels for carbachol, NE, bradykinin, and thrombin, respectively. The EC50 values of IP1 accumulation for carbachol and NE were 34 and 0.16 microM, respectively. The muscarinic antagonists, atropine and pirenzepine, blocked the carbachol-induced IP1 accumulation with Ki values of 0.3 and 30 nM, respectively. The adrenergic antagonist, prazosin, blocked NE-induced IP1 accumulation with a Ki of 0.1 nM. The calcium ionophore A23187, histamine, glutamate, vasopressin, serotonin, platelet activating factor, and substance P did not stimulate IP1 accumulation. A23187, bradykinin, and thrombin stimulated prostacyclin release to approximately four, four, and two times the basal levels, respectively, whereas carbachol and NE had little effect upon prostacyclin release. These results suggest that the activation of phospholipase C and of phospholipase A2 in MCEC are regulated separately.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313855     DOI: 10.1111/j.1471-4159.1992.tb10071.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Arecoline stimulation of radiolabeled arachidonate incorporation from plasma into brain microvessels of awake rat.

Authors:  W M Williams; T Hayakawa; E Grange; S I Rapoport
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

2.  Pharmacological characterization of muscarinic acetylcholine binding sites in human and bovine cerebral microvessels.

Authors:  D G Linville; E Hamel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

3.  Stimulation of phospholipase C in cultured microvascular endothelial cells from human frontal lobe by histamine, endothelin and purinoceptor agonists.

Authors:  J R Purkiss; D West; L C Wilkes; C Scott; P Yarrow; G F Wilkinson; M R Boarder
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

4.  Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury.

Authors:  Jin-Moo Lee; Ping Yan; Qingli Xiao; Shawei Chen; Kuang-Yung Lee; Chung Y Hsu; Jan Xu
Journal:  J Neurosci       Date:  2008-03-19       Impact factor: 6.167

5.  Protein phosphatase 2A regulates bim expression via the Akt/FKHRL1 signaling pathway in amyloid-beta peptide-induced cerebrovascular endothelial cell death.

Authors:  Ke-Jie Yin; Chung Y Hsu; Xiao-Yan Hu; Hong Chen; Sha-Wei Chen; Jan Xu; Jin-Moo Lee
Journal:  J Neurosci       Date:  2006-02-22       Impact factor: 6.167

6.  Interaction between histamine and adenosine in human cerebromicrovascular endothelial cells: modulation of second messengers.

Authors:  D B Stanimirovic; N Bertrand; N Merkel; J Bembry; M Spatz
Journal:  Metab Brain Dis       Date:  1994-09       Impact factor: 3.584

7.  Apoptosis signal-regulating kinase 1 in amyloid beta peptide-induced cerebral endothelial cell apoptosis.

Authors:  Ming-Jen Hsu; Chung Y Hsu; Bing-Chang Chen; Mei-Chieh Chen; George Ou; Chien-Huang Lin
Journal:  J Neurosci       Date:  2007-05-23       Impact factor: 6.167

8.  Exerting the Appropriate Application of Methylprednisolone in Acute Spinal Cord Injury Based on Time Course Transcriptomics Analysis.

Authors:  Liang-Yo Yang; Meng-Yu Tsai; Shu-Hui Juan; Shwu-Fen Chang; Chang-Tze Ricky Yu; Jung-Chun Lin; Kory R Johnson; Hendrick Gao-Min Lim; Yang C Fann; Yuan-Chii Gladys Lee
Journal:  Int J Mol Sci       Date:  2021-12-01       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.